A substance use disorder coverage denial can block residential treatment when an insurer says it isn’t medically necessary. This guide explains medical necessity reviews, parity rules, and level-of-care decisions so you can understand the denial and what to request in an appeal. ReferU.AI can help you get matched with an attorney experienced in ERISA and behavioral health parity disputes.

Type

Grandchild

Status

Approved

Caption

Title (YouTube)

Caption X

Substance Use Disorder Coverage Denials Explained: Parity, Medical Necessity, and Residential Treatment Fights

If you or someone close to you is trying to get substance use disorder treatment covered, a denial can feel disorienting and deeply personal. Families often hear phrases like “not medically necessary,” “lower level of care appropriate,” or “excluded under plan terms” at the exact moment they are trying to stabilize a crisis.

In general terms, these disputes often sit at the intersection of three big issues:

💡

Scroll to the bottom for every post in this series.

Medical necessity — whether the insurer says the requested treatment fits its coverage criteria

Parity — whether the plan applies stricter rules to mental health and substance use treatment than it applies to medical and surgical care

Level of care fights — especially disputes over residential treatment, inpatient rehabilitation, partial hospitalization, and intensive outpatient programs

In this post you’ll learn how these denials usually happen, what parity adds to the conversation, why residential treatment disputes are so common, and how attorneys often evaluate whether a benefits fight may involve ERISA, external review rights, or a larger parity problem. If you want a broader foundation on benefit disputes generally, this overview of ERISA, health-plan denials, appeals, and high-stakes benefit litigation helps place substance use claims in the larger insurance landscape.

What A Substance Use Disorder Coverage Denial Usually Looks Like

A substance use disorder denial does not always arrive as a blunt refusal saying “no treatment.” Often, it appears in more technical forms:

A plan approves detox but denies residential treatment

A plan authorizes only a few days, then cuts off coverage as “no longer acute”

A reviewer says outpatient care is sufficient

A claim is denied because the facility is out of network

A plan says care is custodial, not active treatment

An insurer says the requested setting is not the least restrictive appropriate level of care

A denial letter references internal guidelines without clearly explaining how those guidelines were applied

That last point matters. Under ERISA claims-procedure rules, covered employee benefit plans generally are expected to provide a reasonable opportunity for a full and fair review of a denied claim, and claimants can request relevant documents used or generated in the decision-making process. The U.S. Department of Labor explains these procedural protections in its guidance on group health plan claims procedures and related information-letter guidance on relevant claim records.

Coverage fights over addiction treatment are not rare. SAMHSA reported that 80% of people who needed treatment for a substance use disorder in 2024 did not receive treatment, underscoring how access barriers remain widespread even before you get to the details of insurance appeals (SAMHSA).

Why Medical Necessity Is Usually The Center Of The Dispute

For many plans, the stated reason for denial is medical necessity. That phrase sounds neutral, but in practice it can hide several different disagreements:

What symptoms were documented

Whether relapse risk was described clearly enough

Whether prior lower levels of care failed

Whether co-occurring psychiatric issues were considered

Whether the insurer used the same standard your clinicians used

Whether the review focused too heavily on short-term stabilization rather than ongoing safety and treatment needs

Health plans and external review systems commonly identify medical necessity disputes as a core category of appealable denial. HealthCare.gov explains that internal appeals and external review rights can apply when a plan denies treatment, and external review is available for denials involving medical judgment, including disputes over medical necessity, appropriateness, health care setting, level of care, or effectiveness (HealthCare.gov internal appeals; HealthCare.gov external review glossary; HealthCare.gov external review).

In substance use cases, “medical necessity” often becomes a fight about how severity is measured. Addiction treatment is not always linear. A person may be medically stable enough to leave detox but still face a substantial relapse risk, overdose risk, impaired judgment, unstable housing, co-occurring depression, trauma symptoms, or inability to engage safely at a lower level of care. Insurers and treating providers may frame those same facts very differently.

That is one reason these appeals often turn on clinical detail, not just diagnosis labels. A diagnosis alone may not answer the insurer’s real question: why this level of care, for this patient, at this time?

If you are looking for a more practical breakdown of how these claims are appealed from the ground up, this guide on getting a behavioral-health denial appealed gives a useful starting framework.

What “Parity” Means In Substance Use Disorder Cases

The federal Mental Health Parity and Addiction Equity Act, often called MHPAEA, generally requires that financial requirements and treatment limitations on mental health and substance use disorder benefits are not more restrictive than those applied to medical and surgical benefits in the same classification. Federal agencies have also focused heavily on nonquantitative treatment limitations, or NQTLs — rules like prior authorization, concurrent review, medical necessity criteria, network admission standards, and fail-first requirements that shape access without using obvious visit caps or dollar limits.

The U.S. Department of Labor’s parity materials explain that parity protections apply to both mental health and substance use disorder benefits, and that plans are expected to make medical necessity criteria available in certain circumstances and to analyze whether NQTLs are comparable and applied no more stringently to MH/SUD benefits than to medical/surgical benefits (DOL parity resource guide; DOL FAQ Part 45).

That can matter a great deal in residential-treatment denials. A plan may say it uses neutral medical necessity standards, but parity questions can arise when:

residential SUD treatment faces unusually strict continued-stay review

reviewers demand proof of imminent danger that is not required in analogous medical settings

out-of-network exceptions are harder to obtain for behavioral health than for medical care

the plan covers medical rehabilitation settings more readily than analogous addiction-treatment settings

the insurer relies on internal criteria that appear more restrictive than generally accepted standards

Federal regulators have continued emphasizing parity enforcement. In its 2025 MHPAEA Report to Congress, the Department of Labor stated that since 2021 its NQTL enforcement work had led to over 77,000 group health plans and issuers achieving compliance, reflecting ongoing scrutiny of how plans design and apply utilization-management rules (DOL 2025 MHPAEA Report to Congress). The Departments’ 2024 final rules also expanded and clarified important parity requirements, with some provisions applying for plan years beginning on or after January 1, 2025, and others on or after January 1, 2026 (DOL MHPAEA fact sheet).

Here’s what this often means in practice: a denial may not be just a disagreement about one patient’s chart. It may also involve a broader question about whether the plan’s behavioral-health rules are more restrictive by design or in operation.

For a more detailed look at building this kind of argument, this article on using parity, plan language, and clinical support in an SUD appeal connects the legal and medical pieces.

Why Residential Treatment Fights Are So Common

Residential treatment sits in a particularly contested space. It is intensive and structured, but it is not always viewed by insurers the same way providers and families view it. Plans often frame residential care as appropriate only when outpatient or intensive outpatient treatment is not enough and inpatient hospitalization is not required.

At the same time, addiction medicine relies on established placement frameworks. The American Society of Addiction Medicine explains that The ASAM Criteria uses a multidimensional assessment and level-of-care matching process to identify the least intensive but safe level of care that can meet an individual’s treatment needs. ASAM also states that payers and managed care organizations are expected to use the same dimensional admission criteria when determining coverage for an individual’s level of care (ASAM Criteria overview; ASAM About The Criteria; ASAM Criteria FAQ).

That sounds straightforward, but residential-treatment disputes often arise because different decision-makers interpret the same clinical facts differently. A facility may document:

recent relapse after lower levels of care

unsafe home or recovery environment

impaired ability to adhere to treatment without 24-hour structure

co-occurring mental health conditions

medication-management needs

poor insight, cravings, or functional instability that increase relapse risk

A plan reviewer may respond by emphasizing:

no current withdrawal complication

no active suicidality or psychosis

ability to perform activities of daily living

absence of a medical reason for hospital-level admission

theoretical availability of outpatient care

In other words, the fight is often not whether the patient has a substance use disorder. The real fight is whether the record shows that residential care was the appropriate covered setting.

This issue is important in the real world because residential capacity is a significant part of the treatment system. SAMHSA’s 2024 National Substance Use and Mental Health Services Survey reported 3,596 residential (non-hospital) substance use treatment facilities in the United States, representing 22.5% of surveyed facilities, which helps illustrate how often level-of-care disputes can affect actual access to care (SAMHSA 2024 N-SUMHSS profile).

If the denial specifically involves a residential or intensive outpatient setting, this breakdown on challenging denials for residential and IOP care may help clarify the common pressure points.

What Insurers Often Focus On In Denial Letters

Substance use denial letters frequently rely on recurring themes. The wording changes, but the structure is often similar.

Lack Of “Acute” Symptoms

Some letters focus heavily on emergency-level indicators — for example, severe withdrawal, immediate self-harm risk, or profound medical instability. That framing can understate the clinical value of structured addiction treatment when the key risk is relapse, overdose, treatment nonadherence, or inability to function safely outside a controlled setting.

Incomplete Clinical Documentation

Insurers often argue the file lacks enough objective support. Sometimes that means the treating record did not clearly connect symptoms and history to the requested level of care. Sometimes it reflects an overly narrow reading of the record.

Lower Level Of Care Allegedly Available

Reviewers commonly assert that outpatient or intensive outpatient treatment could address the patient’s needs. But “available” on paper does not always mean clinically realistic in the patient’s actual circumstances.

Progress As A Reason To Stop Coverage

A patient may improve in residential care, only to have the plan cite that improvement as proof the setting is no longer necessary. In some cases, stabilization is treated as the endpoint even when the treatment team views it as the beginning of a vulnerable transition period.

Facility Or Network Issues

Some denials turn on whether the provider is in network, whether preauthorization was obtained, or whether the plan recognizes the facility’s billing structure. These cases can become both coverage fights and administrative fights.

These patterns are one reason procedural discipline matters. Small mistakes can complicate an already difficult dispute. If you want a quick read on avoidable problems, this piece on common behavioral-health denial mistakes that slow treatment covers several issues families often run into.

How Appeals Often Become Evidence Fights

Once a denial is issued, the dispute usually shifts into an evidence problem. The question becomes: what information will the plan reviewer, independent reviewer, or court actually see?

Under federal claims and appeal rules, many plan participants have internal appeal rights, and in urgent cases expedited review may be available. HealthCare.gov explains that internal appeals generally must be filed within 180 days of the denial, and expedited external review decisions may be required as quickly as the medical condition requires, no later than 72 hours after the request is received in qualifying urgent situations (HealthCare.gov internal appeals; HealthCare.gov appeals overview).

In general terms, the strongest substance use appeals often include:

the denial letter and full plan language

medical necessity criteria used by the plan

the utilization review notes

treating-provider letters tied to the requested level of care

records showing failed lower levels of care or repeated relapse

facts about the home environment and recovery supports

parity-related requests and comparisons, where relevant

time-sensitive evidence showing why delay itself creates risk

For employer-sponsored plans governed by ERISA, the appeal can become especially important because the administrative record often carries outsized weight if the case later moves into litigation. The Department of Labor’s ERISA claims guidance explains that plans are expected to provide relevant claim materials on request and to follow procedures that allow a meaningful review of the denial (DOL claims procedure regulation guidance; DOL Information Letter 06-14-2021).

Where External Review Can Change The Conversation

External review can be an important tool in medical necessity disputes, particularly when the conflict is truly clinical rather than purely contractual. CMS and HealthCare.gov explain that independent external review is available for certain denials involving medical judgment, including disputes about level of care and medical necessity (CMS action plan for denied claims; CMS fact sheet on appealing health plan decisions; HealthCare.gov external review).

That does not mean every case belongs in the same lane. Some disputes are mainly about:

plan interpretation

exclusions

residential-treatment wording

network exceptions

parity compliance

procedural irregularities in how the denial was handled

An attorney may help determine whether the better path is an internal appeal, expedited review, parity-focused document requests, external review, ERISA litigation, or a combination of those steps.

When A Denial May Point To A Larger ERISA Or Parity Problem

Sometimes the most important fact is not what the denial letter says outright, but what it omits.

Examples include:

The letter cites “clinical criteria” but does not identify them clearly

The plan refuses to produce criteria or relevant internal notes

The insurer uses language suggesting behavioral-health claims are subject to a different review culture than comparable medical claims

Residential care is treated as exceptional or disfavored in a way that may not have an obvious medical/surgical counterpart

The appeal timeline is compressed while treatment decisions remain highly consequential

Under ERISA, a plan’s failure to establish or follow compliant claims procedures can affect exhaustion issues and the path to court, according to Department of Labor guidance on the benefit claims regulation (DOL claims procedure regulation guidance). Under parity law, plans and issuers are expected to prepare and document comparative analyses for NQTLs, including rules affecting access to behavioral-health treatment (DOL FAQ Part 45; DOL MHPAEA Report to Congress).

Here’s what this often means: the immediate issue may be one residential claim, but the legal story may involve how the plan systematically evaluates substance use treatment.

The Practical Bottom Line

Substance use disorder coverage denials often look technical, but the stakes are intensely human. A short denial letter can interrupt detox-to-residential transitions, delay admission, cut off continued treatment, or push families into paying privately while trying to decipher plan language and clinical criteria.

In general terms, the central questions are usually:

Was the requested level of care supported by the clinical record?

Did the plan apply fair and properly disclosed standards?

Were behavioral-health rules applied more stringently than medical/surgical rules?

Did the claimant receive the full process promised by ERISA, plan terms, and external-review law?

When those questions are answered carefully, some denials begin to look less like isolated utilization decisions and more like document-heavy disputes over parity, level of care, and whether the insurer’s reasoning actually matches the record.

If you’re dealing with a denial involving residential rehab, intensive outpatient treatment, medical necessity, or parity issues, an attorney with demonstrable experience in health-benefit and ERISA disputes may be able to evaluate the record, identify missing documents, and assess whether the denial reflects a broader legal problem rather than just a frustrating one-off decision.

Visit ReferU.AI to get matched with an attorney who has demonstrable experience in cases like yours — for free.

Substance Use Disorder Coverage Denials Explained: Parity, Medical Necessity, and Residential Treatment Fights

Substance Use Disorder Coverage Denials Explained: Parity, Medical Necessity, and Residential Treatment Fights

What A Substance Use Disorder Coverage Denial Usually Looks Like

Why Medical Necessity Is Usually The Center Of The Dispute

What “Parity” Means In Substance Use Disorder Cases

Why Residential Treatment Fights Are So Common